Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07646457
Comparative Effectiveness of Western Pharmacotherapy Versus Integrative Western and Traditional Chinese Medicine for Weight Management in Central Taiwan: A Real-World Cohort StudyNational Yang Ming Chiao Tung UniversityActive Not Recruiting
NCT07646457Active Not Recruiting
—
Comparative Effectiveness of Western Pharmacotherapy Versus Integrative Western...National Yang Ming Chiao...
NCT07644468
Visual Rehabilitation in Children With Autism Spectrum Disorder and Visual DisordersNational Taiwan University HospitalCompletedNot Applicable
NCT07644468Completed
Not Applicable
Visual Rehabilitation in Children With Autism Spectrum Disorder and Visual Disor...National Taiwan Universit...
NCT07646522
Telerehabilitation and Biomarkers of Recovery After Stroke in BrazilAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical SchoolNot Yet RecruitingPhase 2
NCT07646522Not Yet Recruiting
Phase 2
Telerehabilitation and Biomarkers of Recovery After Stroke in BrazilAthinoula A. Martinos Cen...
NCT07646301
Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical CancerSun Yat-sen UniversityRecruitingPhase 2
NCT07646301Recruiting
Phase 2
Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy...Sun Yat-sen University
NCT07644819
Preoperative Outreach to Improve Surgical AttendanceUniversity of California, San FranciscoNot Yet RecruitingNot Applicable
NCT07644819Not Yet Recruiting
Not Applicable
Preoperative Outreach to Improve Surgical AttendanceUniversity of California,...
NCT07643922
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageBeijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07643922Not Yet Recruiting
Not Applicable
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorr...Beijing Tiantan Hospital
NCT07644949
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet UniversityNot Yet RecruitingNot Applicable
NCT07644949Not Yet Recruiting
Not Applicable
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet Univer...
NCT07646145
Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder CancerShanxi Province Cancer HospitalRecruitingPhase 2
NCT07646145Recruiting
Phase 2
Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate-...Shanxi Province Cancer Ho...
NCT07646353
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy AdultsGlaxoSmithKlineNot Yet RecruitingPhase 1
NCT07646353Not Yet Recruiting
Phase 1
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in H...GlaxoSmithKline
NCT07644260
Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric PatientsHospital de Clinicas José de San MartínNot Yet Recruiting
NCT07644260Not Yet Recruiting
—
Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric Patient...Hospital de Clinicas José...
NCT07644299
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept StudyCiusss de L'Est de l'Île de MontréalNot Yet RecruitingNot Applicable
NCT07644299Not Yet Recruiting
Not Applicable
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Co...Ciusss de L'Est de l'Île...
NCT07645326
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Georgetown UniversityNot Yet RecruitingPhase 2
NCT07645326Not Yet Recruiting
Phase 2
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Georgetown University
NCT07644936
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisNot Yet Recruiting
NCT07644936Not Yet Recruiting
—
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Speci...
NCT07644208
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative HepatectomyShanghai Zhongshan HospitalNot Yet RecruitingPhase 2
NCT07644208Not Yet Recruiting
Phase 2
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatoc...Shanghai Zhongshan Hospit...
NCT07643974
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDMedstar Health Research InstituteNot Yet RecruitingEarly Phase 1
NCT07643974Not Yet Recruiting
Early Phase 1
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDMedstar Health Research I...
NCT07645586
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 3
NCT07645586Not Yet Recruiting
Phase 3
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After A...Beijing Tiantan Hospital
NCT07644793
Litter Packaging in the Lateral Position: Effects of Position and Vacuum Mattress Packaging on Pulmonary FunctionUniversity of California, San FranciscoNot Yet RecruitingNot Applicable
NCT07644793Not Yet Recruiting
Not Applicable
Litter Packaging in the Lateral Position: Effects of Position and Vacuum Mattres...University of California,...
NCT07645742
Pilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWest Virginia UniversityNot Yet RecruitingNot Applicable
NCT07645742Not Yet Recruiting
Not Applicable
Pilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWest Virginia University
NCT07644351
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsNovartis PharmaceuticalsCompleted
NCT07644351Completed
—
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lym...Novartis Pharmaceuticals
NCT07645391
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNational Cancer Institute (NCI)Recruiting
NCT07645391Recruiting
—
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNational Cancer Institute...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Not Specified5 (25%)
Phase 25 (25%)
Phase 11 (5%)
Early Phase 11 (5%)
Phase 31 (5%)